NCT04660500

Driving Performance of People With Parkinson's Using Autonomous In-Vehicle Technologies

Completed NA Last updated 19 January 2024

What this trial tests

NA trial testing PD Drivers Using AV Technologies On-road in Parkinson Disease in 112 participants. Completed in 31 August 2023.

Timeline

15 January 2021

Primary endpoint
31 August 2023

31 August 2023

Quick facts

Lead sponsor	University of Florida
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	112
Start date	15 January 2021
Primary completion	31 August 2023
Estimated completion	31 August 2023
Sites	1 location across United States

Drugs / interventions tested

• PD Drivers Using AV Technologies On-road

Conditions studied

• Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

University of Florida

Who can join

Adults 35 to 85, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

For drivers with Parkinson's Disease (PD), autonomous in-vehicle technologies may help mitigate functional deficits, improve driving performance, decrease driving errors and enhance their ability to stay on the road. Using a pretest/posttest design the investigators will quantify the use of In-vehicle Information Systems (IVIS) and Advanced Driver Assistance Systems (ADAS) during driving to illustrate how IVIS and ADAS may affect driving, and provide recommendations to drivers with PD, the clinical community and industry.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. RCT protocol for driving performance in people with Parkinson's using autonomous in-vehicle technologies.
   Classen S, Li Y, Giang W, Winter S, et al · · 2022 · cited 2× · PMID 35812823 · DOI 10.1016/j.conctc.2022.100954